Monitoring universal health coverage within the Sustainable Development Goals: development and baseline data for an index of essential health services 

Slides:



Advertisements
Similar presentations
Monitoring and measuring UHC. 2 Policy and planning Monitoring and Measuring UHC Key Messages Equity is fundamental to UHC – all people get services they.
Advertisements

Volume 390, Issue 10097, Pages (August 2017)
An Early Look at Performance on the Emergency Care Measures Included in Medicare's Hospital Inpatient Value-Based Purchasing Program  Megan McHugh, PhD,
Volume 376, Issue 9755, Pages (November 2010)
How Ethiopia achieved Millennium Development Goal 4 through multisectoral interventions: a Countdown to 2015 case study  Dr Jenny Ruducha, DrPH, Carlyn.
Progress and priorities for reproductive, maternal, newborn, and child health in Kenya: a Countdown to 2015 country case study  Emily C Keats, PhD, Anthony.
Progress and challenges in maternal health in western China: a Countdown to 2015 national case study  Yanqiu Gao, PhD, Hong Zhou, PhD, Neha S Singh, PhD,
Ten Years of Human Papillomavirus Vaccination in the United States
Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study  Alejandra Castanon, MD, Rebecca Landy, PhD,
Demographic and practice factors predicting repeated non-attendance in primary care: a national retrospective cohort analysis  David A Ellis, PhD, Ross.
Socioeconomic inequality in neonatal mortality in countries of low and middle income: a multicountry analysis  Britt McKinnon, MSc, Sam Harper, PhD, Prof.
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
Volume 390, Issue 10097, Pages (August 2017)
Estimating trends in life expectancy in HIV-positive individuals
Achieving maternal and child health gains in Afghanistan: a Countdown to 2015 country case study  Nadia Akseer, MSc, Ahmad S Salehi, MSc, S M Moazzem.
Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment.
Progress on catastrophic health spending in 133 countries: a retrospective observational study  Adam Wagstaff, DPhil, Gabriela Flores, PhD, Justine Hsu,
Cervical cancer incidence can increase despite HPV vaccination
Early antenatal care visit: a systematic analysis of regional and global levels and trends of coverage from 1990 to 2013  Ann-Beth Moller, MPH, Max Petzold,
Progress and challenges in maternal health in western China: a Countdown to 2015 national case study  Yanqiu Gao, PhD, Hong Zhou, PhD, Neha S Singh, PhD,
Volume 376, Issue 9743, (September 2010)
State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household.
Gabriel J Milinovich, Ricardo J Soares Magalhães, Wenbiao Hu 
Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study  Dr Peter J Dodd, PhD, Elizabeth Gardiner, MSc, Renia Coghlan,
Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants 
Association between maternal age at childbirth and child and adult outcomes in the offspring: a prospective study in five low-income and middle-income.
State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household.
Estimating the most efficient allocation of interventions to achieve reductions in Plasmodium falciparum malaria burden and transmission in Africa: a.
Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000  Dr Frédéric B Piel,
Rebalancing the global battle against tuberculosis
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study  Mark Jit, PhD, Marc Brisson, PhD, Allison Portnoy,
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group,
Longitudinal Trends in the Performance of Scientific Peer Reviewers
The contribution of poor and rural populations to national trends in reproductive, maternal, newborn, and child health coverage: analyses of cross-sectional.
Equity in antenatal care quality: an analysis of 91 national household surveys  Catherine Arsenault, PhD, Keely Jordan, MSc, Dennis Lee, BA, Girmaye Dinsa,
Regional contributions of six preventable risk factors to achieving the 25 × 25 non- communicable disease mortality reduction target: a modelling study 
Volume 379, Issue 9822, Pages (March 2012)
Volume 18, Issue 12, Pages (December 2017)
Progress and priorities for reproductive, maternal, newborn, and child health in Kenya: a Countdown to 2015 country case study  Emily C Keats, PhD, Anthony.
Children's height and weight in rural and urban populations in low-income and middle- income countries: a systematic analysis of population-representative.
Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study  Helen C Johnson, MSc, Erin I Lafferty, PhD, Rosalind.
Old-Growth Fishes Become Scarce under Fishing
Measuring health and economic wellbeing in the Sustainable Development Goals era: development of a poverty-free life expectancy metric and estimates for.
Progress on impoverishing health spending in 122 countries: a retrospective observational study  Adam Wagstaff, DPhil, Gabriela Flores, PhD, Marc-François.
Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis  Cynthia Chen, PhD, Francisco Cervero Liceras, MSc, Stefan.
Socioeconomic inequality in neonatal mortality in countries of low and middle income: a multicountry analysis  Britt McKinnon, MSc, Sam Harper, PhD, Prof.
Monitoring equity in universal health coverage with essential services for neglected tropical diseases: an analysis of data reported for five diseases.
Mortality risks in children aged 5–14 years in low-income and middle-income countries: a systematic empirical analysis  Prof Kenneth Hill, PhD, Linnea.
Person-centred maternity care in low-income and middle-income countries: analysis of data from Kenya, Ghana, and India  Patience A Afulani, PhD, Beth.
Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa,
Quality of basic maternal care functions in health facilities of five African countries: an analysis of national health system surveys  Dr Margaret E.
Family income inequalities and trajectories through childhood and self-harm and violence in young adults: a population-based, nested case-control study 
Measuring population ageing: an analysis of the Global Burden of Disease Study 2017  Angela Y Chang, ScD, Prof Vegard F Skirbekk, PhD, Stefanos Tyrovolas,
Estimating the most efficient allocation of interventions to achieve reductions in Plasmodium falciparum malaria burden and transmission in Africa: a.
Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study  Cynthia Schuck-Paim,
Progress towards universal health coverage in Myanmar: a national and subnational assessment  Su Myat Han, MBBS, Md Mizanur Rahman, PhD, Md Shafiur Rahman,
Classification of global measles cases in 2013–17 as due to policy or vaccination failure: a retrospective review of global surveillance data  Minal K.
Low-technology approaches
Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study  Dr Peter J Dodd, PhD, Elizabeth Gardiner, MSc, Renia Coghlan,
Key issues in the persistence of poliomyelitis in Nigeria: a case-control study  Dr Tara D Mangal, PhD, R Bruce Aylward, MD, Michael Mwanza, BComm, Alex.
Volume 379, Issue 9822, Pages (March 2012)
Contribution of socioeconomic factors to the variation in body-mass index in 58 low- income and middle-income countries: an econometric analysis of multilevel.
Double burden of tragedy: stillbirth and obstetric fistula
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation 
Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant.
Screening for cervical cancer: Will women accept less?
Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study  Rebecca C Harris, PhD, Tom Sumner, PhD, Gwenan.
Joan J. Ryoo, MD, MSHS, Jennifer L. Malin, MD, PhD, Diana L
Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15  Prof Peter Lloyd-Sherlock,
Trends in, and projections of, indicators of universal health coverage in Bangladesh, 1995–2030: a Bayesian analysis of population-based household data 
Presentation transcript:

Monitoring universal health coverage within the Sustainable Development Goals: development and baseline data for an index of essential health services  Daniel R Hogan, PhD, Gretchen A Stevens, DSc, Ahmad Reza Hosseinpoor, MD, Ties Boerma, MD  The Lancet Global Health  Volume 6, Issue 2, Pages e152-e168 (February 2018) DOI: 10.1016/S2214-109X(17)30472-2 Copyright © 2018 The World Bank and World Health Organization Terms and Conditions

Figure 1 Calculation of universal health coverage service coverage index on the basis of national levels of coverage IHR=International health regulations. *The percentage of the adult population with non-raised blood pressure is based on age-standardised estimates. These distributions were rescaled to provide a finer resolution for the index, based on the observed minima across countries. †Mean fasting plasma glucose was not measured on a scale bounded by 0 and 100. Although very high concentrations are unhealthy, very low concentrations were not expected to provide additional health benefits and could even be harmful. ‡Cervical cancer screening and access to essential medicines were excluded because of low data availability. §Non-use of tobacco was also based on age-standardised estimates and rescaled to provide finer resolution on the basis of a minimum bound of 50%. ||Hospital bed density values were rescaled and capped on the basis of a threshold of 18 per 10 000 population on the basis of minimum rates observed in high-income Organization for Economic Co-operation and Development countries. ¶Health worker density was rescaled and capped on the basis of threshold values. Physician density had a threshold of 0·9 per 1000, psychiatrists had a threshold of 1 per 100 000, and surgeons had a threshold of 14 per 100 000 population. The Lancet Global Health 2018 6, e152-e168DOI: (10.1016/S2214-109X(17)30472-2) Copyright © 2018 The World Bank and World Health Organization Terms and Conditions

Figure 2 Values for the universal health coverage index of coverage of essential health services and values for each of the tracer indicators used to calculate the index, by country Values were not transformed or rescaled. Country index values of 80 and over are reported as ≥80 for presentation purposes and to avoid comparisons that were not meaningful. For tracer indicators, data are displayed in bold font if primary data were available since 2010, otherwise faded font is used to denote absence of recent primary data. UHC=universal health coverage. DTP3=three doses of diphtheria, tetanus, and pertussis vaccine. *Primary data refers to empirical data collection; availability of comparable estimates was higher than availability of primary data. Primary data availability was calculated as the percentage of indicators for which primary data since 2010 were available. For the purpose of this calculation, the three health-worker density indicators were treated as one indicator. †Most recent year of data available was used. Year of data for each indicator reported from each country is available in the appendix. ‡Estimates for the percentage of cases treated are for 2014, whereas estimates of cases detected are for 2015. §Estimates are for 2008. The Lancet Global Health 2018 6, e152-e168DOI: (10.1016/S2214-109X(17)30472-2) Copyright © 2018 The World Bank and World Health Organization Terms and Conditions

Figure 2 Values for the universal health coverage index of coverage of essential health services and values for each of the tracer indicators used to calculate the index, by country Values were not transformed or rescaled. Country index values of 80 and over are reported as ≥80 for presentation purposes and to avoid comparisons that were not meaningful. For tracer indicators, data are displayed in bold font if primary data were available since 2010, otherwise faded font is used to denote absence of recent primary data. UHC=universal health coverage. DTP3=three doses of diphtheria, tetanus, and pertussis vaccine. *Primary data refers to empirical data collection; availability of comparable estimates was higher than availability of primary data. Primary data availability was calculated as the percentage of indicators for which primary data since 2010 were available. For the purpose of this calculation, the three health-worker density indicators were treated as one indicator. †Most recent year of data available was used. Year of data for each indicator reported from each country is available in the appendix. ‡Estimates for the percentage of cases treated are for 2014, whereas estimates of cases detected are for 2015. §Estimates are for 2008. The Lancet Global Health 2018 6, e152-e168DOI: (10.1016/S2214-109X(17)30472-2) Copyright © 2018 The World Bank and World Health Organization Terms and Conditions

Figure 2 Values for the universal health coverage index of coverage of essential health services and values for each of the tracer indicators used to calculate the index, by country Values were not transformed or rescaled. Country index values of 80 and over are reported as ≥80 for presentation purposes and to avoid comparisons that were not meaningful. For tracer indicators, data are displayed in bold font if primary data were available since 2010, otherwise faded font is used to denote absence of recent primary data. UHC=universal health coverage. DTP3=three doses of diphtheria, tetanus, and pertussis vaccine. *Primary data refers to empirical data collection; availability of comparable estimates was higher than availability of primary data. Primary data availability was calculated as the percentage of indicators for which primary data since 2010 were available. For the purpose of this calculation, the three health-worker density indicators were treated as one indicator. †Most recent year of data available was used. Year of data for each indicator reported from each country is available in the appendix. ‡Estimates for the percentage of cases treated are for 2014, whereas estimates of cases detected are for 2015. §Estimates are for 2008. The Lancet Global Health 2018 6, e152-e168DOI: (10.1016/S2214-109X(17)30472-2) Copyright © 2018 The World Bank and World Health Organization Terms and Conditions

Figure 2 Values for the universal health coverage index of coverage of essential health services and values for each of the tracer indicators used to calculate the index, by country Values were not transformed or rescaled. Country index values of 80 and over are reported as ≥80 for presentation purposes and to avoid comparisons that were not meaningful. For tracer indicators, data are displayed in bold font if primary data were available since 2010, otherwise faded font is used to denote absence of recent primary data. UHC=universal health coverage. DTP3=three doses of diphtheria, tetanus, and pertussis vaccine. *Primary data refers to empirical data collection; availability of comparable estimates was higher than availability of primary data. Primary data availability was calculated as the percentage of indicators for which primary data since 2010 were available. For the purpose of this calculation, the three health-worker density indicators were treated as one indicator. †Most recent year of data available was used. Year of data for each indicator reported from each country is available in the appendix. ‡Estimates for the percentage of cases treated are for 2014, whereas estimates of cases detected are for 2015. §Estimates are for 2008. The Lancet Global Health 2018 6, e152-e168DOI: (10.1016/S2214-109X(17)30472-2) Copyright © 2018 The World Bank and World Health Organization Terms and Conditions

Figure 3 Median tracer indicator value across countries grouped by universal health coverage index quintile and country distribution of rescaled inputs to the index The plot shows the distribution of values for the 183 countries included in the analysis. DTP3=three doses of diphtheria, tetanus, and pertussis vaccine. *Physicians per 1000 values are shown with rescaled health worker density score distribution, which combines physician, surgeon, and psychiatrist densities. The Lancet Global Health 2018 6, e152-e168DOI: (10.1016/S2214-109X(17)30472-2) Copyright © 2018 The World Bank and World Health Organization Terms and Conditions

Figure 4 Regional (population-weighted) means for the UHC service coverage index and its four component sub-indices, by modified SDG region UHC=universal health coverage. SDG=Sustainable Development Goal. The Lancet Global Health 2018 6, e152-e168DOI: (10.1016/S2214-109X(17)30472-2) Copyright © 2018 The World Bank and World Health Organization Terms and Conditions

Figure 5 UHC service coverage index at a national level, and estimated for the poorest wealth quintile UHC= universal health coverage. Patterns of relative inequality for family planning; antenatal care; diphtheria, pertussis, and tetanus vaccine; and access to at least basic sanitation are represented. Countries with high data availability since 2010 are depicted. The Lancet Global Health 2018 6, e152-e168DOI: (10.1016/S2214-109X(17)30472-2) Copyright © 2018 The World Bank and World Health Organization Terms and Conditions